Work

Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy

Year: 2020

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1111/bjh.16494

Authors: Stephen D. Smith, Brian G. Till, Mazyar S. Shadman, Ryan C. Lynch, Andrew J. Cowan, Qian V. Wu, Jenna Voutsinas, Heather A. Rasmussen, Katherine Blue, Chaitra S. Ujjani, Andrei Shustov, Ryan D. Cassaday, Jonathan R. Fromm, Ajay K. Gopal

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Merck Sharp and Dohme, National Cancer Institute

Awards: Molecularly Targeted Therapy for Lymphoma, Cancer Center Support Grant

OpenAlex ID: W3005263041

FWCI: 11.11

Cites: 39

Cited by: 94

Related to: 10